Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

Related stories

CNBC·6m ago

Kimberly Guilfoyle resigns as ambassador to Greece at White House's request

The White House has asked U.S. Ambassador to Greece Kimberly Guilfoyle to resign, press secretary Katie Zacharia said Tuesday in her debut briefing.

CNBC·11m ago

Iran reportedly fortifies nuclear sites as it prepares for possible U.S. strikes after midterms

A Saudi-led coalition fighting the Houthis – a Yemeni militant group backed by Tehran – said it had intercepted another attack on Riyadh.

CNBC·19m ago

AI companion startup Character.ai files for Chapter 11 bankruptcy, citing costs and litigation

The company said the platform became "costly to develop and grow," in Monday filings to the Delaware District bankruptcy court.

BBC Business·23m ago

The Sabrina Carpenter clip which helped a 22-year-old make £120,000 a year

Social media "clippers" make short, vertical videos that appear on the likes of Instagram and TikTok.

CNBC·31m ago

UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs

UnitedHealth Group said it expects 2026 adjusted earnings of at least $20.50 per share, up from a previous outlook of $19.50 to $20.00 per share.

The Guardian·36m ago

Companies rushed in on AI. Now some are pulling back

Rapid AI adoption left workers cleaning up a flood of errors and low-quality work Employers around the globe are grappling with the fallout from rushing to adopt fast-changing artificial intelligence tools. Meta has scaled back plans to axe staff and use more AI agents after the company found employees were spending more and more time cleaning up technical and security errors, Reuters reported . And after thinning its workforce, especially middle managers , in a 2023 efficiency push, the company is expanding its managerial ranks again, LinkedIn posts from workers show. Continue reading...